Injectco Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: compounded GLP-1s from a Texas medspa chain that also ships nationwide
Injectco scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. Its compounded semaglutide costs $249 a month, 25% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
InjectCo runs nine medspa clinics in Texas and also sells compounded semaglutide and tirzepatide online. Its own pages list two prices for compounded semaglutide ($249 and $425 a month) and two for a 6-8 month starter supply ($1,249 and $1,800). Tirzepatide is $425 a month. Medication comes from an unnamed 503B pharmacy, and the site says it serves patients across the United States.
Is Injectco legit?
Yes. Injectco is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.6/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an Injectco promo or coupon code?
We know of no promo or coupon code for Injectco. Its listed price is $249 a month. Coupon sites advertising "Injectco discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Injectco compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Injectco
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Bodybuilding Health+
Best for: seeing what it charges before you answer any medical questions
Editorial score · methodology
Injectco at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo
- What's included
- Medication · Consult
- FDA status
- No FDA warning letters found
How Injectco scores
Six columns, each one computed from something Injectco has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.4/10$249/month is 25% above the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.5/10The price covers the medication and clinician visits.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Injectco
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Injectco
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Injectco involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Injectco shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Injectco which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and clinician visits.
- Lowest ongoing monthly price: semaglutide $249, tirzepatide $425. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Injectco serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Injectco
- Phone
- (214) 234-9684
- Hours
- 8am-8pm | 7 days
Medications Injectco lists
Injectco lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
$249 a month on the compounded semaglutide page; the program page lists $425 a month. A 6-8 month supply at the starting dose is $1,249 (from $1,599) on the GLP-1 page and $1,800 on the payment-plans page.
"$425 per month program" with automatic monthly refills.
Check the price yourself before you pay
Every figure here comes from Injectco's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to Injectco
Against it
- Semaglutide costs $249 a month, 25% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $425 a month, 58% above the $269 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Injectco charges
The standing price at Injectco is $249/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
- Compounded semaglutide: $249/month
- Compounded tirzepatide: $425/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Injectco's $249 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Wellorithm dispenses semaglutide and tirzepatide from $247/month, which makes it the fair comparison to run before you commit here.
What Injectco dispenses
Injectco prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Injectco tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to Injectco. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Injectco will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Injectco bills your plan before you start.
Our read
Injectco costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. Direct Meds is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Injectco scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. Its compounded semaglutide costs $249 a month, 25% above the $199 median among the sellers we compare.
Before you pay Injectco
Starting at $249 a month. Check today's price, then start the intake.
Where Injectco is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Injectco sets more sellers in the same category beside Injectco on price, states and what the price includes.
Frequently Asked Questions
How to check Injectco yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Injectco review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Injectco's current pricing
Plans start at $249 a month. Whether you qualify is a clinician's decision, made after your intake.